These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8830834)

  • 1. Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients.
    Langman LJ; LeGatt DF; Halloran PF; Yatscoff RW
    Transplantation; 1996 Sep; 62(5):666-72. PubMed ID: 8830834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inosine monophosphate dehydrogenase expression and activity are significantly lower in kidney transplant recipients with diabetes mellitus.
    Dostalek M; Gohh RY; Akhlaghi F
    Ther Drug Monit; 2013 Jun; 35(3):374-83. PubMed ID: 23666569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex.
    Valvezan AJ; McNamara MC; Miller SK; Torrence ME; Asara JM; Henske EP; Manning BD
    JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32271165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetically controlled drug resistance: how Penicillium brevicompactum survives mycophenolic acid.
    Sun XE; Hansen BG; Hedstrom L
    J Biol Chem; 2011 Nov; 286(47):40595-600. PubMed ID: 21979957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Clinical Manifestation of Immunosuppressive Therapy as a Tool to Improve Immune Monitoring in Renal Transplant Recipients.
    Scott N; Ben-David A; Davidov Y; Cohen-Hagai K; Yemini R; Ghinea R; Mor E; Hod T
    Kidney Blood Press Res; 2023; 48(1):445-459. PubMed ID: 37231964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic drug monitoring in kidney and liver transplantation: current advances and future directions.
    Ntobe-Bunkete B; Lemaitre F
    Expert Rev Clin Pharmacol; 2024; 17(5-6):505-514. PubMed ID: 38725273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of mycophenolic acid exposure in a patient with immune-related hepatotoxicity caused by nivolumab and ipilimumab therapy for malignant melanoma: a case report.
    Suzuki Y; Ishiguro S; Shimada H; Ohgami M; Suzuki M
    Cancer Chemother Pharmacol; 2024 Jun; 93(6):633-638. PubMed ID: 38148336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Pharmacokinetics of Mycophenolic Acid in Elderly Renal Transplant Recipients Compared to a Younger Control Group: Data from the nEverOld Trial.
    Romano P; Agena F; de Almeida Rezende Ebner P; Massakazu Sumita N; Kamada Triboni AH; Ramos F; Dos Santos Garcia M; Coelho Duarte NJ; Brambate Carvalhinho Lemos F; Zocoler Galante N; David-Neto E
    Eur J Drug Metab Pharmacokinet; 2019 Apr; 44(2):189-199. PubMed ID: 30229398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of mycophenolate mofetil for IgA nephropathy: An updated meta-analysis of randomized controlled trials.
    Zheng JN; Bi TD; Zhu LB; Liu LL
    Exp Ther Med; 2018 Sep; 16(3):1882-1890. PubMed ID: 30186414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats.
    Jia Y; Wang R; Li L; Zhang Y; Li J; Wang J; Wang X; Qi G; Rong R; Xu M; Zhu T
    BMC Pharmacol Toxicol; 2018 Jul; 19(1):39. PubMed ID: 29973291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?
    Rasche FM; Keller F; Rasche WG; Schiekofer S; Boldt A; Sack U; Fahnert J
    Clin Exp Immunol; 2016 Nov; 186(2):115-133. PubMed ID: 27283488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.
    Wagner M; Earley AK; Webster AC; Schmid CH; Balk EM; Uhlig K
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007746. PubMed ID: 26633102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inosine monophosphate dehydrogenase activity in paediatrics: age-related regulation and response to mycophenolic acid.
    Rother A; Glander P; Vitt E; Czock D; von Ahsen N; Armstrong VW; Oellerich M; Budde K; Feneberg R; Tönshoff B; Weber LT
    Eur J Clin Pharmacol; 2012 Jun; 68(6):913-22. PubMed ID: 22274404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patients.
    Sommerer C; Müller-Krebs S; Schaier M; Glander P; Budde K; Schwenger V; Mikus G; Zeier M
    Br J Clin Pharmacol; 2010 Apr; 69(4):346-57. PubMed ID: 20406219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transplanted child: New immunosuppressive agents and the need for pharmacokinetic monitoring.
    Filler G; Feber J
    Paediatr Child Health; 2002 Oct; 7(8):525-32. PubMed ID: 20046464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic evaluation of the first dose of mycophenolate mofetil before kidney transplantation.
    Kamar N; Glander P; Nolting J; Böhler T; Hambach P; Liefeldt L; Rostaing L; Neumayer HH; Budde K
    Clin J Am Soc Nephrol; 2009 May; 4(5):936-42. PubMed ID: 19339413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance therapy with mycophenolate mofetil for children with severe lupus nephritis after low-dose intravenous cyclophosphamide regimen.
    Fujinaga S; Ohtomo Y; Hara S; Umino D; Someya T; Shimizu T; Kaneko K
    Pediatr Nephrol; 2008 Oct; 23(10):1877-82. PubMed ID: 18414900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome.
    Fujinaga S; Ohtomo Y; Umino D; Takemoto M; Shimizu T; Yamashiro Y; Kaneko K
    Pediatr Nephrol; 2007 Jan; 22(1):71-6. PubMed ID: 17086405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children.
    Filler G; Hansen M; LeBlanc C; Lepage N; Franke D; Mai I; Feber J
    Pediatr Nephrol; 2003 May; 18(5):445-9. PubMed ID: 12687454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic monitoring of mycophenolate mofetil in organ transplant recipients: is it necessary?
    Mourad M; Wallemacq P; König J; de Frahan EH; Eddour DC; De Meyer M; Malaise J; Squifflet JP
    Clin Pharmacokinet; 2002; 41(5):319-27. PubMed ID: 12036390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.